Circio Holding ASA - Asset Resilience Ratio

Latest as of June 2026: 18.36%

Circio Holding ASA (CRNA) has an Asset Resilience Ratio of 18.36% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CRNA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Nkr100.17 Million

≈ $10.54 Million USD Cash + Short-term Investments

Total Assets

Nkr545.56 Million

≈ $57.41 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Circio Holding ASA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see CRNA total asset value.

Liquid Assets Composition Over Time

This chart breaks down Circio Holding ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read CRNA liabilities breakdown for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Nkr0.00	0%
Short-term Investments	Nkr100.17 Million	18.36%
Total Liquid Assets	Nkr100.17 Million	18.36%

Asset Resilience Insights

Good Liquidity Position: Circio Holding ASA maintains a healthy 18.36% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Circio Holding ASA Industry Peers by Asset Resilience Ratio

Compare Circio Holding ASA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS F:A71	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Abivax SA American Depositary Shares NASDAQ:ABVX	Biotechnology	2.58%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Kailera Therapeutics, Inc. Common Stock NASDAQ:KLRA	Biotechnology	64.92%
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	Biotechnology	78.22%
Beijing Hotgen Biotech Co Ltd SHG:688068	Biotechnology	20.87%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%

Annual Asset Resilience Ratio for Circio Holding ASA (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Circio Holding ASA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	81.73%	Nkr17.84 Million ≈ $1.88 Million	Nkr21.83 Million ≈ $2.30 Million	+0.78pp
2023-12-31	80.95%	Nkr20.81 Million ≈ $2.19 Million	Nkr25.71 Million ≈ $2.71 Million	+18.24pp
2022-12-31	62.71%	Nkr62.97 Million ≈ $6.63 Million	Nkr100.41 Million ≈ $10.57 Million	+31.19pp
2021-12-31	31.52%	Nkr178.18 Million ≈ $18.75 Million	Nkr565.27 Million ≈ $59.48 Million	+8.66pp
2020-12-31	22.86%	Nkr119.07 Million ≈ $12.53 Million	Nkr520.74 Million ≈ $54.80 Million	--

pp = percentage points

About Circio Holding ASA

OL:CRNA Norway Biotechnology

Market Cap

$293.06 Million

Nkr2.78 Billion NOK

Market Cap Rank

#15057 Global

#120 in Norway

Share Price

Nkr10.16

Change (1 day)

-1.74%

52-Week Range

Nkr0.60 - Nkr14.40

All Time High

Nkr676.52